Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-06

Clinical Trial Results: A Fabry Disease Gene Therapy Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results for a Fabry disease gene therapy were posted after termination of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fabry disease gene therapy

Snippet

Sponsor: Spur Therapeutics | Conditions: Fabry Disease, Lysosomal Storage Diseases | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-06